HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurent Lamalice Selected Research

2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamide

11/2017Selective HIF-1 Regulation under Nonhypoxic Conditions by the p42/p44 MAP Kinase Inhibitor PD184161.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurent Lamalice Research Topics

Disease

4Hypoxia (Hypoxemia)
11/2017 - 08/2012

Drug/Important Bio-Agent (IBA)

3Oxygen (Dioxygen)IBA
11/2017 - 08/2012
2Transcription Factors (Transcription Factor)IBA
01/2016 - 08/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2017
1Hormones (Hormone)IBA
11/2017
12- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamideIBA
11/2017
1Phosphates (Orthophosphate)IBA
01/2016
1roxadustatIBA
01/2016
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
08/2014
1ElementsIBA
08/2012